Vor Biopharma Inc. (VOR) NASDAQ
$2 (0.07) (-3.15%)
Market Cap: $139.47M
As of 10/04/23 04:00 PM EDT. Market closed.

Vor Biopharma Inc. (VOR)
NASDAQ
$2
(0.07) (-3.15%)
Market Cap: $139.47M
As of 10/04/23 04:00 PM EDT. Market closed.
vor biopharma is pioneering engineered hematopoietic stem cells (ehscs) to dramatically change the treatment paradigm for hematological cancers. vor’s ehscs are designed to generate healthy, fully functional cells with specific advantageous modifications, for example to protect the blood and bone marrow from the toxic effects of antigen-targeted therapies, protecting healthy cells from ... read more
vor biopharma is pioneering engineered hematopoietic stem cells (ehscs) to dramatically change the treatment paradigm for hematological cancers. vor’s ehscs are designed to generate healthy, fully functional cells with specific advantageous modifications, for example to protect the blood and bone marrow from the toxic effects of antigen-targeted therapies, protecting healthy cells from depletion but leaving tumor cells vulnerable. vor’s platform could potentially be used to change the treatment paradigm of both hematopoietic stem cell transplants and antigen-targeted therapies such as antibody drug conjugates, bispecific antibodies and car-t cell treatments. a proof-of-concept study for vor’s lead program has been published in proceedings of the national academy of sciences. vor is based in cambridge, mass. and has a broad intellectual property base including in-licenses from columbia university, where foundational work was conducted by inventor and vor scientific board chair siddhar read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Jorgensen Nathan D. | Chief Financial Officer | Sep 01, 2023 | Option Exercise | $2.67 | 6,310 | 16,848 | 146,481 | Sep 06, 2023, 04:31 PM |
Chakraborty Tirtha | Chief Scientific Officer | Sep 01, 2023 | Option Exercise | $2.67 | 5,576 | 14,888 | 134,828 | Sep 06, 2023, 04:29 PM |
ANG ROBERT | President and CEO | Sep 01, 2023 | Option Exercise | $2.67 | 12,657 | 33,794 | 683,286 | Sep 06, 2023, 04:28 PM |
Chakraborty Tirtha | Chief Scientific Officer | Aug 07, 2023 | Option Exercise | $2.67 | 875 | 2,336 | 140,404 | Aug 09, 2023, 04:38 PM |
Jorgensen Nathan D. | Chief Financial Officer | Aug 07, 2023 | Option Exercise | $2.67 | 834 | 2,227 | 152,791 | Aug 09, 2023, 04:37 PM |
Attar Eyal C. | Chief Medical Officer | Aug 07, 2023 | Option Exercise | $2.67 | 999 | 2,667 | 52,532 | Aug 09, 2023, 04:31 PM |
ANG ROBERT | President and CEO | Aug 07, 2023 | Option Exercise | $2.67 | 2,361 | 6,304 | 695,943 | Aug 09, 2023, 04:29 PM |
ANG ROBERT | President and CEO | May 08, 2023 | Option Exercise | $4.14 | 2,361 | 9,775 | 698,304 | May 10, 2023, 04:19 PM |
Chakraborty Tirtha | Chief Scientific Officer | May 08, 2023 | Option Exercise | $4.14 | 875 | 3,622 | 141,279 | May 10, 2023, 04:18 PM |
Jorgensen Nathan D. | Chief Financial Officer | May 08, 2023 | Option Exercise | $4.14 | 834 | 3,453 | 153,625 | May 10, 2023, 04:16 PM |
Attar Eyal C. | Chief Medical Officer | May 08, 2023 | Option Exercise | $4.14 | 969 | 4,012 | 53,531 | May 10, 2023, 04:14 PM |
ANG ROBERT | President and CEO | Mar 01, 2023 | Option Exercise | $5.51 | 12,657 | 69,740 | 700,665 | Mar 02, 2023, 06:39 PM |
Chakraborty Tirtha | Chief Scientific Officer | Mar 01, 2023 | Option Exercise | $5.51 | 5,576 | 30,724 | 142,154 | Mar 02, 2023, 06:37 PM |
Jorgensen Nathan D. | Chief Financial Officer | Mar 01, 2023 | Option Exercise | $5.51 | 6,310 | 34,768 | 154,459 | Mar 02, 2023, 06:35 PM |
Jorgensen Nathan D. | Chief Financial Officer | Mar 01, 2023 | Option Exercise | $5.51 | 6,310 | 34,768 | 154,459 | Mar 02, 2023, 06:35 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Dec 09, 2022 | Option Exercise | $4.30 | 11,627,907 | 50,000,002 | 20,923,554 | Dec 09, 2022, 04:32 PM |
5AM Ventures VI, L.P. | 10% Owner | Nov 16, 2021 | Sale | $15.30 | 330,706 | 5,059,802 | 4,595,089 | Nov 18, 2021, 08:14 PM |
PARMAR KUSH | Director | Nov 16, 2021 | Sale | $15.30 | 330,706 | 5,059,802 | 4,595,089 | Nov 18, 2021, 08:10 PM |
Chakraborty Tirtha | Chief Scientific Officer | Aug 17, 2021 | Option Exercise | $1.36 | 17,446 | 23,727 | 20,980 | Aug 19, 2021, 04:02 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Feb 09, 2021 | Buy | $18.00 | 2,979,566 | 53,632,188 | 8,297,265 | Feb 09, 2021, 06:25 PM |
5AM Ventures VI, L.P. | 10% Owner | Feb 09, 2021 | Buy | $18.00 | 555,555 | 9,999,990 | 4,833,959 | Feb 09, 2021, 06:03 PM |
PARMAR KUSH | Director | Feb 09, 2021 | Buy | $18.00 | 555,555 | 9,999,990 | 4,833,959 | Feb 09, 2021, 05:15 PM |
Owner | Relationship | Date | Value($) |
Jorgensen Nathan D. | Chief Financial Officer | 09/01/2023 | 16,848 |
Chakraborty Tirtha | Chief Scientific Officer | 09/01/2023 | 14,888 |
ANG ROBERT | President and CEO | 09/01/2023 | 33,794 |
Chakraborty Tirtha | Chief Scientific Officer | 08/07/2023 | 2,336 |
Jorgensen Nathan D. | Chief Financial Officer | 08/07/2023 | 2,227 |
Attar Eyal C. | Chief Medical Officer | 08/07/2023 | 2,667 |
ANG ROBERT | President and CEO | 08/07/2023 | 6,304 |
ANG ROBERT | President and CEO | 05/08/2023 | 9,775 |
Chakraborty Tirtha | Chief Scientific Officer | 05/08/2023 | 3,622 |
Jorgensen Nathan D. | Chief Financial Officer | 05/08/2023 | 3,453 |
Attar Eyal C. | Chief Medical Officer | 05/08/2023 | 4,012 |
ANG ROBERT | President and CEO | 03/01/2023 | 69,740 |
Chakraborty Tirtha | Chief Scientific Officer | 03/01/2023 | 30,724 |
Jorgensen Nathan D. | Chief Financial Officer | 03/01/2023 | 34,768 |
Jorgensen Nathan D. | Chief Financial Officer | 03/01/2023 | 34,768 |
RA CAPITAL MANAGEMENT, L.P. | Director | 12/09/2022 | 50,000,002 |
5AM Ventures VI, L.P. | 10% Owner | 11/16/2021 | 5,059,802 |
PARMAR KUSH | Director | 11/16/2021 | 5,059,802 |
Chakraborty Tirtha | Chief Scientific Officer | 08/17/2021 | 23,727 |
RA CAPITAL MANAGEMENT, L.P. | Director | 02/09/2021 | 53,632,188 |
5AM Ventures VI, L.P. | 10% Owner | 02/09/2021 | 9,999,990 |
PARMAR KUSH | Director | 02/09/2021 | 9,999,990 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 22,780,343 | 1.11% | 0.14% | Other |
BLACKROCK INC. | 2,164,732 | 0.00018% | 362.95% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 722,405 | 0.00026% | 128.65% | Other |
BAKER BROS. ADVISORS LP | 633,848 | 0.01% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 36,400 | 0.00016% | 28.17% | Other |
Period of Report: 06/30/2023
10-K/10-Q Filings: View